Abstract: Provided herein are methods and systems for detecting non-nutritive sucking (NNS) by an infant in a video recording and determining the start and end times of the NNS. The NNS detection method includes creating video segments from the video recording. For each video segment, action recognition is performed that includes determining a face bounding box for each frame of the video segment. The frames are cropped based on the bounding box. For each cropped frame, an optical flow frame is generated of the optical flow direction vectors for pixels of the cropped frame. Using a convolution network and the optical flow frames, a segment feature vector is determined from the pre-classification feature layer of the convolution network. The segment feature vector corresponding to each video segment is used as input to a dilated convolution network to predict an NNS action and determine the start and end time of the NNS.

Abstract: Disclosed herein are immunogenic and/or vaccine compositions and methods for treating or preventing Severe acute respiratory syndrome (SARS). The compositions and methods include an immunogenic portion of the receptor-binding domain (RBD) of the SARS-CoV-2-2 (COVID-19) spike protein. In at least particular cases, a mutated version of a portion of the RBD is utilized, such as a deglycosylated, or amino acid substituted mutant of the spike protein.

Abstract: Disclosed herein are immunogenic and/or vaccine compositions and methods for treating or preventing Severe Acute Respiratory Syndrome (SARS). The compositions and methods include an immunogenic portion of the receptor-binding domain (RBD) of the SARS-CoV-2-2 (COVID-19) spike protein. In at least particular cases, a mutated version of a portion of the RBD is utilized, such as a deglycosylated, or amino acid substituted mutant of the spike protein.

Abstract: Provided herein are methods and systems for identifying a face of an infant in an image including providing a computer comprising a processor and a memory trained with a set of training images and programmed with a convolutional neural network (CNN) model for identifying a face of an infant in a test image suspected of comprising an infant's face, wherein each image of the set of training images includes a plurality of facial landmark annotations and at least one pose attribute annotation, providing a test image suspected of comprising an image of an infant's face, and processing the test image using the computer, whereby the infant's face is identified in the test image.

Abstract: Systems and methods are disclosed for monitoring routing data and issuing alarms for route anomalies detected based on the monitored routing data. Routing data, including Border Gateway Protocol (BGP) announcement and/or withdraw messages for a targeted prefix of an Autonomous System (AS), is collected and analyzed to detect route anomalies. The analysis may include a comparison of the BGP messages to internal routing data. An alarm is selectively output corresponding to the detected route anomalies. The detected route anomalies may be correlated with monitored network traffic data to classify the route anomalies, where the output of the alarm is based on the classification of the route anomalies.

Abstract: Disclosed herein are immunogenic and/or vaccine compositions and methods for treating or preventing Severe Acute Respiratory Syndrome (SARS). The compositions and methods include an immunogenic portion of the receptor-binding domain (RBD) of the SARS-CoV-2-2 (COVID-19) spike protein. In at least particular cases, a mutated version of a portion of the RBD is utilized, such as a deglycosylated, or amino acid substituted mutant of the spike protein.

Abstract: Disclosed herein are immunogenic and/or vaccine compositions and methods for treating or preventing Severe acute respiratory syndrome (SARS). The compositions and methods include an immunogenic portion of the receptor-binding domain (RBD) of the SARS-CoV-2-2 (COVID-19) spike protein. In at least particular cases, a mutated version of a portion of the RBD is utilized, such as a deglycosylated, or amino acid substituted mutant of the spike protein.

Abstract: Disclosed herein are immunogenic and/or vaccine compositions and methods for treating or preventing Severe acute respiratory syndrome (SARS). The compositions and methods include an immunogenic portion of the receptor-binding domain (RBD) of the SARS-CoV-2-2 (COVID-19) spike protein. In at least particular cases, a mutated version of a portion of the RBD is utilized, such as a deglycosylated, or amino acid substituted mutant of the spike protein.

Abstract: A system of and method for maintaining data objects in containers across a network of distributed heterogeneous resources in a manner which is transparent to a client. A client request pertaining to containers is resolved by querying meta data for the container, processing the request through one or more copies of the container maintained on the system, updating the meta data for the container to reflect any changes made to the container as a result processing the request, and, if a copy of the container has changed, changing the status of the copy to indicate dirty status or synchronizing the copy to one or more other copies that may be present on the system.